- Home >
- Clinicals Trials >
- PEACE 7
Back to clinical trials list
PEACE 7
A randomised Phase III trial with a factorial design evaluating the efficacy and safety of darolutamide and stereotactic dose escalated radiotherapy in patients with localised prostate cancer and high-risk features of relapse, from the Prostate Cancer Consortium in Europe (PEACE).
- Open at Paris since : 21/07/2025
- Open at Saint-Cloud since : 08/10/2025
- Target : Adult
- Phase : Phase III
Trial description
Primary endpoint (estimated):;Metastasis-free survival (MFS) À time from randomization to detection of metastasis or death.;Secondary endpoints (estimated):;Progression-free survival (PFS), clinical or biochemical;Overall survival (OS);Safety/tolerability and adverse events;Quality of life assessments;Time to next systemic therapy or symptomatic skeletal events
Url of the trial
